Provisional ban on "Inside contract" positively proceeded.

Published: 1999-08-09 10:51:00

Updated: 1999-08-09 10:51:00

The KPMA took an amendment of the people's health insurance law and "Fair competition rule pertaining to the medical insurance drug deals" for a provision to disclose and accuse unfair trade acts breaching among hospitals, drug makers and wholesalers to the public prosecutor in dealing process of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK